MED vs. NE
MED (Medifast, Inc.) and NE (Noble Corporation) are both stocks. MED operates in Personal Services (Consumer Cyclical), while NE operates in Oil & Gas Drilling (Energy). Over the past 5 years, MED returned -45.89%/yr vs 17.16%/yr for NE. At a 0.14 correlation, their price movements are largely independent.
Performance
MED vs. NE - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, MED achieves a 11.33% return, which is significantly lower than NE's 69.84% return.
MED
- 1D
- -0.25%
- 1M
- -4.73%
- YTD
- 11.33%
- 6M
- -3.80%
- 1Y
- -8.40%
- 3Y*
- -46.74%
- 5Y*
- -45.89%
- 10Y*
- -7.29%
NE
- 1D
- 1.73%
- 1M
- -10.32%
- YTD
- 69.84%
- 6M
- 61.33%
- 1Y
- 70.26%
- 3Y*
- 13.81%
- 5Y*
- 17.16%
- 10Y*
- —
MED vs. NE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
MED Medifast, Inc. | 11.33% | -39.39% | -73.79% | -38.34% | -42.31% | -28.57% |
NE Noble Corporation | 69.84% | -3.21% | -31.57% | 29.54% | 52.00% | 1.27% |
Correlation
The correlation between MED and NE is 0.06, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.06 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.11 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.14 |
Correlation (All Time) Calculated using the full available price history since Jun 9, 2021 | 0.14 |
Fundamentals
MED:
$130.86M
NE:
$7.55B
MED:
-$1.82
NE:
$1.43
MED:
0.38
NE:
2.35
MED:
0.66
NE:
1.65
MED:
$346.10M
NE:
$3.20B
MED:
$242.70M
NE:
$716.15M
MED:
-$3.86M
NE:
$1.11B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
MED vs. NE — Risk / Return Rank
MED
NE
MED vs. NE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Medifast, Inc. (MED) and Noble Corporation (NE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| MED | NE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.97 | ||
| Sortino ratioReturn per unit of downside risk | -2.48 | ||
| Omega ratioGain probability vs. loss probability | 0.99 | 1.29 | -0.29 |
| Calmar ratioReturn relative to maximum drawdown | -0.26 | 4.28 | -4.54 |
| Martin ratioReturn relative to average drawdown | -0.44 | 9.03 | -9.47 |
Loading charts...
Drawdowns
MED vs. NE - Drawdown Comparison
The maximum MED drawdown since its inception was -98.40%, which is greater than NE's maximum drawdown of -63.16%. Use the drawdown chart below to compare losses from any high point for MED and NE.
Loading charts...
Drawdown Indicators
| MED | NE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -98.40% | -63.16% | -35.24% |
Max Drawdown (1Y)Largest decline over 1 year | -37.39% | -16.56% | -20.83% |
Max Drawdown (3Y)Largest decline over 3 years | -90.91% | -63.16% | -27.75% |
Max Drawdown (5Y)Largest decline over 5 years | -96.29% | -63.16% | -33.13% |
Max Drawdown (10Y)Largest decline over 10 years | -96.76% | — | — |
Current DrawdownCurrent decline from peak | -95.96% | -12.75% | -83.21% |
Average DrawdownAverage peak-to-trough decline | -50.84% | -19.49% | -31.35% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 21.83% | 7.83% | +14.00% |
Volatility
MED vs. NE - Volatility Comparison
The current volatility for Medifast, Inc. (MED) is 8.94%, while Noble Corporation (NE) has a volatility of 10.86%. This indicates that MED experiences smaller price fluctuations and is considered to be less risky than NE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| MED | NE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 8.94% | 10.86% | -1.92% |
Volatility (6M)Calculated over the trailing 6-month period | 31.69% | 29.03% | +2.66% |
Volatility (1Y)Calculated over the trailing 1-year period | 41.90% | 40.86% | +1.04% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 45.25% | 43.44% | +1.81% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 47.68% | 43.39% | +4.29% |
Dividends
MED vs. NE - Dividend Comparison
MED has not paid dividends to shareholders, while NE's dividend yield for the trailing twelve months is around 4.26%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
MED Medifast, Inc. | 0.00% | 0.00% | 0.00% | 7.36% | 5.69% | 2.71% | 2.30% | 3.08% | 1.75% | 2.06% | 2.57% | 0.82% |
NE Noble Corporation | 4.26% | 7.08% | 5.73% | 1.45% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
MED vs. NE - Financials Comparison
This section allows you to compare key financial metrics between Medifast, Inc. and Noble Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
MED vs. NE - Profitability Comparison
MED - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Medifast, Inc. reported a gross profit of 51.76M and revenue of 76.04M. Therefore, the gross margin over that period was 68.1%.
NE - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Noble Corporation reported a gross profit of 305.45M and revenue of 785.69M. Therefore, the gross margin over that period was 38.9%.
MED - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Medifast, Inc. reported an operating income of -3.30M and revenue of 76.04M, resulting in an operating margin of -4.3%.
NE - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Noble Corporation reported an operating income of 225.31M and revenue of 785.69M, resulting in an operating margin of 28.7%.
MED - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Medifast, Inc. reported a net income of -2.12M and revenue of 76.04M, resulting in a net margin of -2.8%.
NE - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Noble Corporation reported a net income of 120.73M and revenue of 785.69M, resulting in a net margin of 15.4%.
Frequently Asked Questions
MED and NE have a correlation of 0.06, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
NE has higher volatility (10.86%) compared to MED (8.94%). In terms of maximum drawdown, MED dropped -98.40% vs NE's -63.16%.
NE currently has the higher Sharpe Ratio (1.73 vs -0.23), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for MED and NE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer